Same old story, more and more validation acheived (when does it stop?). Licences signed, but falling revenue (meaning tests unlikely occured. When will cash flow occur?). Again no elaboration on the business rollout model (why is that? Is there no overarching plan?) = inability for investors to forecast possible future cash flows. A lot of grey areas. Cash burn would be signigicant would it not be for the R&D grant.
Sorry, a bit harsh, but not impressed to say the least.
Ann: December 2020 Quarterly Activities Report and Appendix 4C, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $49.87M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.5¢ | 28.5¢ | $201.7K | 642.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3253 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 57411 | 2 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |